Legal Liability in Clinical Trials: Volunteer Rights and Obligations of Pharmaceutical Companies

1. Introduction

Clinical trials are essential for evaluating the safety and efficacy of pharmaceuticals and medical devices. However, beyond their scientific importance, these trials involve significant legal and ethical responsibilities. The rights of volunteers, the obligations of sponsoring pharmaceutical companies, and the judicial review of ethics committee decisions are among the key issues under Turkish law.

2. Contractual Structure and Parties in Clinical Trials

Clinical trials typically involve three main parties:

• Sponsor (usually a pharmaceutical company)
• Investigator (a physician or healthcare institution)
• Volunteer participants

Contracts signed between these parties regulate issues such as sponsorship, data sharing, confidentiality, liability, and compensation. The contract provisions must be supported by the volunteer’s informed consent.

3. Volunteer Rights and Compensation Claims

Under Turkish law, volunteers are granted special protection concerning personal rights and bodily integrity. According to the Fundamental Law on Health Services (No. 3359) and the Regulation on Clinical Trials of Drugs and Biological Products:

• Volunteers have the right to withdraw from the study at any time.
• If any harm occurs during the trial, they have the right to claim compensation.
• Compensation is typically covered by insurance policies provided by the sponsor.

4. Role of Ethics Committees and Judicial Review

All clinical trials must be approved by an Ethics Committee before initiation. The committee evaluates:

• The scientific rationale of the study,
• Protective measures for volunteers’ rights,
• The adequacy of informed consent forms.

Since the decisions of ethics committees are administrative in nature, they are subject to judicial review. If an application is rejected or a study is suspended, the sponsor or investigator may file an annulment case before an administrative court.

5. Legal Responsibilities of Pharmaceutical Companies

Sponsor companies are directly responsible for:

• Compensating any harm suffered by volunteers,
• Providing sufficient insurance coverage,
• Ensuring compliance with both national and international regulations,
• Adhering to data privacy and ethical principles.

If the sponsor does not have a legal entity in Turkey, they must appoint a legal representative.

6. Alignment with International Regulations

Turkey has aligned its legal framework with international ethical guidelines such as Good Clinical Practice (GCP) and the Declaration of Helsinki. This ensures the protection of volunteer rights at an international standard, especially in multi-center clinical trials.

7. Conclusion

Clinical trials are not only essential to public health but also deeply affect individual rights and freedoms. To protect volunteers from harm and clearly define the obligations of pharmaceutical companies, both the ethical and legal frameworks must be carefully implemented. In this context, transparency, informed consent, oversight, and compensation mechanisms are indispensable components of the rule of law